HeyJaredEndocrine News Podcast
Endocrine News Podcast, a free service of the Endocrine Society, features interviews with experts addressing the latest research and trends in the field of endocrinology. Let us know what you’d like to hear about in a future episode at podcast@endocrine.org.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 10, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 3, 2026
Latest episodes
Type 1 Diabetes and Pregnancy (opens the original)
Read excerpt
Before the availability of insulin therapy, diabetes was a contraindication to pregnancy. It was recommended that women with type 1 diabetes (T1D) not get pregnant. Today, with intensive insulin therapy, many tools exist to care for people with T1D. Nevertheless, pregnant women with T1D are still considered to have high-risk pregnancies, and susceptible to complications such as fetal overgrowth, or having a large baby. Complications of T1D and pregnancy was the topic of a presentation by Camille
Bisphenols and the Thyroid (opens the original)
Read excerpt
This episode looks at bisphenols and the thyroid, asking questions such as: What is BPA? Where is it found? And what do we know about the possible health risks regarding exposure to it? Host Aaron Lohr talks with Kailey Caroland, a cancer biology PhD candidate at Vanderbilt University School of Medicine, about her ENDO 2026 abstract on the topic titled, "Bisphenol A, and Alternative Bisphenols S, F, Increase Proliferation and Growth of Thyroid Follicular Epithelial Cells and Disrupt Thyroid Hist
Impact of Androgen Receptors on Estrogen Receptor-Positive Breast Cancer Microenvironments (opens the original)
Read excerpt
Estrogen receptor positive breast cancer (ER+ BC) is the most frequently diagnosed subtype of BC with consequent highest mortality. For patients with ER+ BC, standard of care treatments are endocrine therapies targeting ER expression and activity or aromatase inhibitors that block synthesis of estrogens from adrenal androgens. However, it is estimated that nearly 33% of all patients with ER+ BC will relapse within 15 years, underscoring the need for additional therapeutic options This episode fo
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.